Companies

Onepot AI

onepot.ai

AI-powered custom synthesis platform automating small molecule creation for drug development.

Employees1-10
Funding$13M
1 active role
Healthcare AIAI ApplicationB2B SaaSSeed$10M-$50M

About

Onepot AI is an AI-powered custom synthesis CRO that automates the creation of small molecules for drug development using computational methods and robotic systems. They offer a platform called onepot CORE that enables the search of 2.7 billion synthesizable molecules. The company targets the biotechnology and pharmaceutical industries to accelerate high-throughput experimentation.

Active Roles

1

Key Investors

Fifty Years, Khosla Ventures, Speedinvest, Norrsken VC, Script Capital